TY - JOUR
T1 - FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study
AU - Morganti, Alessio Giuseppe
AU - Mignogna, Samantha
AU - Caravatta, Luciana
AU - Deodato, Francesco
AU - Macchia, Gabriella
AU - Plantamura, Nunzio M.
AU - Massaccesi, Mariangela
AU - Picardi, Vincenzo
AU - Cilla, Savino
AU - Valentini, Vincenzo
PY - 2014
Y1 - 2014
N2 - To evaluate the effectiveness of low-dose radiation therapy (LDRT) and FOLFIRI-bevacizumab (FOLFIRI-B) combination in metastatic colorectal cancer.
AB - To evaluate the effectiveness of low-dose radiation therapy (LDRT) and FOLFIRI-bevacizumab (FOLFIRI-B) combination in metastatic colorectal cancer.
KW - Bevacizumab,
KW - Chemo-sensitization,
KW - Low-dose radiotherapy,
KW - Metastatic colorectal cancer
KW - Bevacizumab,
KW - Chemo-sensitization,
KW - Low-dose radiotherapy,
KW - Metastatic colorectal cancer
UR - http://hdl.handle.net/10807/63820
U2 - 10.1179/1973947813Y.0000000163
DO - 10.1179/1973947813Y.0000000163
M3 - Article
SN - 1120-009X
VL - 26
SP - 353
EP - 358
JO - Journal of Chemotherapy
JF - Journal of Chemotherapy
ER -